SODIUM SULFACETAMIDE, SULFUR

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: SODIUM SULFACETAMIDE, SULFUR
Generic name: SULFACETAMIDE SODIUM AND SULFUR
Manufacturer: Westminster Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 4478ac49-8984-42db-9b9e-bea6346a6955
SPL ID: 4fe0b59c-b850-44db-9670-a7499c724fea
Version: 8
Effective date: 2020-05-21
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:42:01

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		SODIUM SULFACETAMIDE, SULFUR	openfda.brand_name
generic name		SULFACETAMIDE SODIUM AND SULFUR	openfda.generic_name
manufacturer name		Westminster Pharmaceuticals, LLC	openfda.manufacturer_name
ndc	package	69367-244-10	openfda.package_ndc
ndc	product	69367-244	openfda.product_ndc
ndc11	package	69367024410	derived:openfda.package_ndc
rxcui		1494169	openfda.rxcui
spl id		4fe0b59c-b850-44db-9670-a7499c724fea	id
spl set id		4478ac49-8984-42db-9b9e-bea6346a6955	set_id
unii		4NRT660KJQ	openfda.unii
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF REACH OF CHILDREN.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.